Takeaways: PixCell Medical’s Health Canada license and distribution partnership with Inter Medico give HemoScreen a direct route into Canada’s growing point-of-care diagnostics ma...
Felix Health launches sleep apnea care in Canada through collaboration with MedSleep Felix Health announced the launch of sleep apnea care across Ontario, British Columbia, and Alberta through a new c...
Takeaways: The Canadian government’s funding supports Kardium’s plan to expand manufacturing and cleanroom capacity in Vancouver, enabling the company to scale production of its Globe Pulsed Fie...
Takeaways: Felix’s sleep apnea program, built with MedSleep, creates a virtual front door for one of Canada’s most under‑diagnosed chronic conditions (≈1 in 4 adults at high risk, only ~3%...
Takeaways: Knight Therapeutics’ Canadian launch of WYNZORA strengthens its dermatology portfolio and marks the commercialization of a product it inherited through the Paladin acquisition. The launch a...
Takeaways: Roche Canada’s completion of pCPA negotiations for Perjeta (pertuzumab) in the neoadjuvant setting (with trastuzumab + chemotherapy) for HER2‑positive, locally advanced, inflammatory...
Takeaways: CDA‑AMC’s positive, conditional reimbursement recommendation for Nucala (mepolizumab) in adults with COPD and raised blood eosinophils who remain uncontrolled on ICS/LABA/LAMA triple therap...
Takeaways: The expanded approval of Lynkuet for AET‑related VMS gives Canadian oncologists and breast cancer patients the first non‑hormonal, evidence‑based option specifically indicated for...
Takeaways: Light AI’s Health Canada Class II license for QuickScan Strep A clears the way to commercialize an AI‑based clinical decision support tool that analyzes digital throat images to h...
Takeaways: Slenyto gives Canadian clinicians a prescription, extended‑release melatonin specifically studied for children and teens (ages 2 to <18) with autism spectrum disorder and/or Smith‑Mageni...
